Over the last five years, FDA and ICH quality initiatives created a paradigm shift in pharmaceutical discovery, development, and manufacturing. At the 17th International Process Development Conference, Christine Moore gave a presentation on the FDA perspective on Quality by Design (QbD) in pharmaceutical development. During her presentation, Christine discussed the advantages that the U.S. Food and Drug Administration (FDA) believes Quality by Design offers, including: Continue reading
METTLER TOLEDO is pleased to announce that Dr. Martin D. Johnson of Eli Lilly won the award for Best Paper at the 17th International Process Development Conference (IPDC).
This two part crystallization webinar series given by Mark Barrett on January 27 and February 3 is now available on-demand. View the Optimization and Scale-up of a Hydrodynamically Limited Anti-Solvent Crystallization Process on-demand webinar.
The webinar series, based on an award winning paper presented at the 16th International Process Development Conference, focuses on a semi-quantitative method for the optimization and scale-up of hydrodynamically limited anti-solvent crystallization process. This protocol combines in situ Process Analytical Technologies (PAT) with Computational Fluid Dynamics (CFD) to facilitate the production of a knowledge based scale-up strategy for this mixing limited crystallization process.
The International Process Development Conference (IPDC) is an annual meeting, hosted by METTLER TOLEDO, which brings together industrial and academic researchers focused on chemical and pharmaceutical process research, scale-up, and manufacturing.
Past conferences have received extremely high marks for the value of the information shared by industry and the quality networking opportunities. Registration discounts are available for university researchers and for users of METTLER TOLEDO automated lab reactors and process analytical technologies.
Conference agenda will include sessions on: